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ABSTRACT
IBD (inflammatory bowel disease) is a pandemic chronic disease of the
gastrointestinal tract inducing Ulcerative colitis (UC) and Crhon disease (CD). The
inflammation of colon especially associated with the growing risk of developing colon
cancer. To extend the research on IBD, chemical mice models are investigated on easy
way to induce colitis in rodent. Dextran sulfate salt (DSS) 7 days, 3% in drinking water
induce IBD on mice. One of the problem of DSS is that it requires a purification step of
mRNA by LiCl. This step induce this mRNA harvest rate quantitatively and qualitatively.
In this study, we synthesized Pullulan Sulfate and Cyclodextrin Sulfate as
alternative colitis inducers in mice. The specificity of sulfated polysaccharides in colon
versus small intestine has been confirmed by common gastrointestinal method (pro
inflammatory cytokines causes degradation of the epithelium, and the presence of blood
in stool.)

INDEX WORDS: IBD, mice model, DSS, mRNA purification, Pullulan and Cyclodextrin.
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1
1.1

INTRODUCTION

A brief introduction of inflammatory bowel disease
Inflammatory bowel disease is a group of diseases occurring in the bowel

system. Main one named Crohn’s disease (CD, occurring in all digestive track) and
ulcerative colitis (UC, mainly colon) are the basic types of inflammatory bowel disease
(1).
With a high morbidity and high mortality in developing area such as North Africa,
China and India, IBD remains to be one of the most severe diseases around the
world.(2) Patients suffer reduce intestine-stomach colic, long-term diarrhea, body weight
losing and blood stools physically. Most of them also meet psychosocial problem like
anxiety and depression on mental. This is especially a severe social problem which will
lead patients to worry about their behavior and increase their anxiety disorder (1-3).
CD is an inflammatory bowel disease is a multifactorial disease (infection,
heredity, cellular immunity) which mechanisms still keeps unknown.
IBD in Asia— during the past two decades, IBD reports and prevalence has a
striking rising. According a study 2007, as a model of developed country, Japan has the
prevalence of UC risen from 78 reports per million individuals to 636 reports per million
individuals. Another studies on Singapore IBD prevalence, UC prevalence has
increased from 60 reports per million individuals to 86 reports per million individuals,
and the prevalence of CD has risen from 13 reports per million individuals to 72 reports
per million individuals. As in Korea, there has also been a substantial rise in the
prevalence of UC—from 76 reports per million individuals in 1997 to 309 reports per
million individuals in 2007 (6,8).
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Reasons that might responsible for the rising prevalence of IBD in Asia likely
including

industrialization

of

societies,

deterioration

of

environmental

factors

(Westernization of lifestyle included), changes in diet (with the increasing economy,
Asians eat more meat than mid 20th century), a huge advancement sanitation, and
possibly, increasing using of antibiotics in medical treatment. In almost countries in
Asia, antibiotics can now be extremely easily obtained from any pharmacy facility, in
some areas, antibiotics are even not prescription drug. The assumption that antibiotic
use earlier in childhood may augment the risk of IBD is hold by several case-control
studies conducted in the West (9).
In Asia UC is over number CD, relatively much as it was in the other areas like
Europe and north America (6.7) But, preliminary evidence also suggests that CD would
overtake UC in developing countries over time (6.7.8).
IBD in America—An increase in the number of IBD patients is also continually
shown, reflecting a rising need for more research to find a cure. In United states, about
1.6 million Americans are currently reported have IBD, An organization named Crohn’s
and Colitis foundation of Americans (CCFA) is monitoring the IBD spreading and
situation of IBD patients. According to their recent reports, a growth of Approximate
200,000 since the last time CCFA reported IBD population (in 2011). Every year, Mor6e
than 70,000 new cases of IBD are diagnosed in the United States. What is worse? A
significant part of them are children—thenre may be as many as 80,000 children in the
United States with IBD in total.
Due to highly developed medical condition and clinic technology, circumstance of
IBD carriers are getting better and better. Based on the publications of CCFA,

3

biochemists have identified over 160 genes related to IBD. Investigation of these genes
will revolutionize our understanding of Crohn’s disease and ulcerative colitis mechanism
and form the basis for investigating new drugs and equipment (10).
1.1.1 Different types of IBDs
CD and UC are the most common IBD. CD is more likely to be reported in
western world, while UC is more common in Asia (11).
Table 1: Overall difference between UC and CD

Difference
Inflammatory
disorder
Position

exterior

Pain
Bleeding

1.1.1.1

UC
Inflammation
will
be
continuous
throughout affected areas
Large intestine is basically the
specifically affected site
Colon wall is thinner and shows
continuous
inflammation
Mucus lining of large intestine may
have ulcers, but they do not extend
beyond the inner lining
Pain occurs in the lower left part of the
abdomen
Bleeding from the rectum during bowel
movements

CD
Inflammation might periodically occur in
patches
Inflammation may attack anywhere
along the gastrointestinal tract
Large intestine wall may be thickened
and may have a rocky appearance
Ulcers along the digestive track are
deep and may extend into all layers of
the bowel wall
Pain is commonly taken place in the
lower right abdomen
Bleeding from the rectum during bowel
movements is not common

Crohn’s disease

CD—it is named after Dr. Burrill B. Crohn that is first physician who described the
disease in 1932. When talking about inflammatory bowel diseases, it is fundamental to
realize that CD is not the same thing as UC, another type of IBD. These two IBDs share
quite similar symptoms, but differ from areas affected in the gastrointestinal tract (GI
tract).
The end of the small bowel (the ileum) and the beginning of the colon is mostly
affected by Crohn’s, while it is able to affect any part of the gastrointestinal (GI) tract,
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thus, from the esophagus to the anal opening. UC is just limited to the colon part, also
called the large intestine, from cecum to rectum (14).

Figure 1: Crohn's disease, http://gastro.seoimportant.com/gi-diseases-and-conditions/crohns-disease

CD is also able to attack the whole thickness of the bowel wall, while UC only
involves the innermost lining of the large intestine. Finally, in CD, the inflammation of
the intestine can “skip”—leaving functional areas between patches of diseased
intestine. In UC this does not occur.
The symptoms patients might experience:
Common—skin rash, slow growth, acute episodes, arthritis, depression, mouth
ulcer, anal fissure, and bodyweight loss.
Pain—severe pain in the rectum, abdomen, low abdomen or joints.
Body—vomit, nausea and fever (13.15).
1.1.1.2

Ulcerative colitis

Ulcerative colitis—is a colon chronic disease, also known as a basic type of IBD, which
is the lining of the large intestine becomes inflamed and develops extremely small out
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sores, or ulcers, that generate pyaemia and mucous. The integration of inflammation
and ulceration is able to cause gastrointestinal pain and periodic emptying of the colon.
UC is the result of an abnormal response by your body's immune system. Normally, the
cells and proteins that make up the immune system protect you from infection. In people
with IBD, however, the immune system mistakes food, bacteria, and other materials in
the intestine for foreign or invading substances. When this happens, the body sends
white blood cells into the lining of the intestines, where they produce chronic
inflammation and ulcerations (16).

Figure 2: ulcerative colitis, http://www.ulcerativecolitis.net/colitis

It’s significant to tell the difference between ulcerative colitis and Crohn's disease. UC
affects only the large intestine, on the other hand CD can affect any part of the
Gastrointestinal (GI) Tract, from oral cavity to anus. Furthermore, while Crohn’s disease
is able to attack any layers of the bowel system, ulcerative colitis only affects the inner
of the colon.
The symptoms patients might experience:
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Common—scarring within the bile ducts or weight loss.
Pain—intermittent abdominal pain, joints or rectum pain.
Abdominal—tenderness or cramping.
Gastrointestinal—diarrhea, constipation, urgent need of defecation, colon tissue
bloating, blood in stool, bowels empty inability, or leaking of stool (16.17).

Table 2: different symptoms of ulcerative colitis (UC) and Crohn’s disease (CD

Symptoms of Ulcerative Colitis
Anemia caused by severe bleeding
Abdominal pain or discomfort
Urgent bowel movements
Loss of appetite
Rectal bleeding
Bloody diarrhea
Malabsorption
Dehydration
Weight loss
Fatigue
Joint pain
Fever

Symptoms of Crohn's Disease
Abdominal pain, cramping or
swelling
Persistent or recurrent diarrhea
Gastrointestinal bleeding
Stomach ulcers
Malabsorption
Weight loss
Joint pain
Vomiting
Anemia
Fever

1.1.2 Research model.
Among the advantages to use mouse model, the most important is their striking
similarity to humans in anatomy, physiology, and genetics. Over 95% of the mouse
genome is similar to our own, making mouse genetic research particularly applicable to
human disease.
Practically, mice are a cost-effective and efficient tool to speed research and the
development of drug therapies. Mice are small and have a short generation time
required to perform accelerated preliminary research experiments.
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In addition, our ability to directly manipulate the mouse genome provides an
incredibly powerful tool to model specific diseases for which the causative gene is
known. For example, Ulcerative .colitis can be induced by knocking down IL-10.
1.1.3 Common methods used to induce IBD mice model

SO3H
NO2

NO2

NO2
Figure 3: Semi-developed formula of 2, 4, 6-trinitro benzene sulfonic acid

2, 4, 6-trinitro benzene sulfonic acid (TNBS), dextran sulfate sodium (DSS) and
oxazolone are mostly research used inflammatory bowel disease inducers on mouse
model.
2, 4, 6-trinitro benzene sulfonic acid (TNBS) model—The reason of TNBS
induced colitis is because of susceptible strains of animals, for example rats, mice and
rabbit. It will be delivered by instillation of the complex of TNBS and ethanol. Why
ethanol is necessary is because it can break the mucosal barrier, so that TNBS can
associated to large intestine autologous or microbial proteins having an interaction with
the host immune system, which is supposed to be immunogenic.
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As we know, CD 4+ T cells have already performed as a central role in TNBS
induced colitis, this kind of colitis is usually used in studying T helper cell-dependent on
the strain and independent modification of the concentrations of TNBS administered is
necessary. Especially for generating colonic colitis.
Oxazolone colitis—oxazolone is another well-known reagents that research
people widely used to induce inflammatory bowel disease on rodent animal like mouse.
Mice skin will be painted with 2.5 percent oxazolone dissolved in 100 percent ethanol
for first 2 days, then painted with 2.5 percent oxazolone dissolved in 50 percent ethanol
in the following a week. Mice will be characterized by their daily body weight change
rate, diarrhea, length of colon and bloody stools. In oxazolone colitis mice model, only
distal colon and particularly mucosal layers will be attacked by the inflammatory disease.
Just like what has been observed in human ulcerative colitis, histology test has shown
that, Th2 cytokines, for example IL-6, TNF-alpha and P53 has dramatically increased
compare to normal tissue. According to this discovery, this model will be a good choice
for ulcerative colitis model.

Ph

N
OEt
O
O

Figure 4: Semi-developed formula of oxazolone
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Dextran sulfate sodium colitis—in
in recent research, DSS is more used compared
to TNBs and oxazolone. Because it is much more easy to use
use—directly
directly dissolved into
drinking water. No need to inject reagent into mice anal, or make an organic solution
then smear it onto mice skin. Mice will be treated with 3 percent DSS into drinking
water, and over a duration of 7 days, mice will have a severe inflammatory bowel
disease.

Figure 5: Semi-developed
developed formula of dextran sulfate sodium.

The degree of substitution is 2. C2 and C4 is sulfated. The acute colitis DSS
induced will be characterized by daily body weight change ratio or bloody diarrhea.
Through the exactly reason of DSS is still keep unknown. There are 2 possible
hypotheses is extensively accepted.
DSS may be directly toxic to gut epithelial cells of the colon crypts, which will
affects the quantity of the mucosal barrier. The other assumption is that DSS will inhibit
quantitative reverse-transcription
transcription polymerase chain reaction (qRT
(qRT-PCR)..
Dextran sulfate
lfate sodium is also used to induce chronic inflammatory bowel
disease. Mice will be treated with 1 percent DSS water solution in drinking water for the
first 5 days, then just water is offered to mice for another 5 days. And this circle is
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repeated for 135 days. A very severe IBD is induced, which can be characterized by the
mice daily body weight change, bloody diarrhea and length of colon. Histology methods
will be helpful to detect the severity of IBD. Especially, 45 days is slight inflammation, 90
days is more serious while 90 days tissue is deadly, the whole colon is inflammatory,
and the villus crypt is destroyed.
1.1.4 Pullulan
Pullulan also named as
asα-1,4- ;α-1,6-glucan, is unique linear polysaccharide,
polysac
which is consisted with 3 glucose subunit named maltotriose. The so called moltotriose
is make up with three glucose, which is bonded with α-1,4 glycosidic bonds.
bond while the
maltotrioses are connected of 3 glucoses, which is connected withα-1,4
with
withα
glycosidic
bonds.
s. it has a high similarity to Dextran.

Figure 6: Semi-developed
developed formula of pullulan
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Figure 7: Semi-developed formula of beta-cyclodextrin.

Cyclodextrin is a family of polysaccharides that made up of several sugar

moleculars bound in a ring. Beta-cyclodextrin is made of 7 glucose, which are
connected with α-1, 4 glucosidic bond. This ring polysaccharide is generated by
enzymatic conversion. They are often used in food, drug, chemical industry and
pharmacy.
Beta-cyclodextrin is consisted with 7 members in a ring. Starch and cyclodextrin
glycosyltransferase are involved in the synthesie of cyclodextrin.

2

EXPERIMENT

In this section we described, our methods including synthesis of pullulan sulfate
(PS) and Cyclodextrin sulfate (CS), animal experiment, surgical procedures, western
blot, immunofluorescence, immunohistochemistry, histology, gravimetric method,
infrared and NMR.
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2.1

Organic chemistry experiment
Pullulan sulfate and Cyclodextrin sulfate are synthesized, chlorosulfonic acid is

used as sulfate agent.
1

H NMR and

13

C NMR spectrums of pullulan sulfate are obtained with bruker

600M instrument.
Infrared spectrums of pullulan and pullulan sulfate are acquired by perkin elmer.
2.1.1 Synthesis of polysaccharide sulfate
Our idea to use pullulan sulfate and cyclodextrin as alternative to DSS is
innovative as there is no sulfated pullulan or cyclodextran available on the market.
Synthesis of PS and CS are achieved by pyridine- SO3 complex.

Figure 8: synthesis reaction. Sulfonic acid is used to react with pyridine, pyridine-sulfate complex is
generated, which will act as sulfate agent in the secondary step.

Materials.—Pullulan was purchased from Tokyo Chemical Industry CO., LTD,

(MW=2*105g/mol).

Beta-Cyclodextrin

was

obtained

from

ACROS

ORGANIC.

(MW=1134.98).
Agents.—all the agents used were of analytical grade. The formamide is
obtained from ACROS ORGANIC. 99% for molecular biology.
Preparation of the pyridine – -SO3 complex –40 ml pyridine was cooled in -20 ℃
for 30 min. Then the pyridine with 2-neck flask was submerged into 1: 3 ratio salt ice

13

mixture. Nitrogen was blowing into the flask as protection for 10 min, then the flask was
isolated from air with rubber flask caps. 16 ml Chlorosulfonic acid was added to the
flask drop by drop in the fuming cupboard in case of Chlorosulfonic acid smoke was
made (8ml Chlorosulfonic acid is added drop by drop in order to get a low sulfate
degree compound, named PS I. while the higher sulfate degree compound obtained by
adding double equilibrium of Chlorosulfonic is named PS II. CS II is at high degree of
substitution. ). During adding the Chlorosulfonic acid, stirring was turn to medium level
to break the pyridine –SO3 complex (solid) for a better reaction efficiency. A constant
stirring is applied. The complex was put in the ice-salt mixture for next step.
Synthesis—20ml of water free formamide was added into the flask for
homogeneous reaction mixture. When all the pyridine –SO3 complex solid was
dissolved, 2g of pullulan or cyclodextrin was weight and slowly added into the flask with
the stirring on. A balloon of nitrogen was connected to the isolated reaction system to
block oxygen and water from air and balance pressure. Set the heater to 85 ℃ (65, 80,
85, 90 degree were used to obtain different degree of substitution).The reaction
temperature was monitored. The sulfonation reaction took 4 h (continuous heating and
stirring).
Purification—100 ml ultrapure water was frozen in -80 ℃ then break to pieces.
Then all the mixture was decanted into 1: 1 ultrapure water ice mixture. The mixture
was stirred for 30 min to make sure all the mixture was cool down and dissolved. Then
the solution was poured to 400 ml methyl alcohol for precipitation. After that, it was
separated by centrifuge (5000 rpm for 10 min). This step was repeated 3 times, then the
precipitate was redissolved by water and transfer to salt form by adding 10ml 5 M NaOH
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solution. The salt solution was dialysed against water for 1 days (Water was changed
every 6 h). Then sample was dialysed against ultrapure water for 3 day with constant
stirring to get rid of ion and small impurities. Sample was precipitated with methyl
alcohol again, then dissolved with water (in order to increase yield, water volume 30
mL). Liquid nitrogen was used to quick freeze the whole flask. Then the flask was
connected with lypholizer. Powder sample was obtained after 10 h. Dry sample was
stored against air.
2.1.2

13

C NMR spectrum

13

C NMR spectrums were obtained by a 400M nuclear magnetic resonance

spectrometer (bruker analytics) applying the Pulse Fourier Transform procedure.
Deuterium (99.9 atom % D, alorich) oxide was used as solvent for

13

C NMR. And

deuterium dimethylsulfoxide (99.9 atom % D, alorich) was used as 1H NMR solvent.
Factors: program zg. NS: 2048. DS: 4.
2.1.3 Infrared spectrum
Infrared spectrum was obtained by a Fourier transform infrared spectroscopy
(Nicolet iS10 from Thermo Scientific). Water free samples were mixed with potassium
bromide. The spectrometer worked in the wave range from 4000 to 650 cm-1 in room
temperature. The reference measurement was performed with a pure potassium
bromide. Spectrometer’s Fourier self deconvolution function finished Final evaluation.
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2.2

Biological experiment
PS I, PS II and CS was given to mice in drinking water (3%). DSS, Pullulan are

used as reference groups (3%). Respectively for colitis inducer, mice body weight was
measured daily.
2.2.1 Animal experiment
All mice were grouped by 5 mice per cage at our animal facility Georgia State
University, under controlled conditions of light (12:12 hour dark/light cycle), 5% humidity
and 25˚C. All animal experiments were approved by the Institutional Animal Care and
Use Committee of Georgia State University (Atlanta, GA), and in accordance with the
guide for the Care and Use of Laboratory Animals by U.S. Public Health Service.
Wild type mice were from Deltagen (San Mateo, CA). 25 mice were evenly
divided to 5 group: Pullulan group, Pullulan sulfate I group, Pullulan sulfate II group,
DSS group, cyclodextrin group and cyclodextrin sulfate group. The concentration was
fixed at 3% in drinking water.
Mice were sacrificed after 1 weeks. Large intestine length was recorded. Livers,
small intestines, colons, spleens, hearts, lungs were collected and put in -80 ℃.
2.2.2 PCR
2.2.2.1

TRIZOL RNA Isolation

Homogenization– tissue were homogenized in 2 ml of TRIZOL reagent per 100
mg of tissue using a glass-Teflon or power homogenizer (OMNI international LH96Automatic homogenizer workstation). The sample volume should not exceed 10% of the
volume of TRIZOL Reagent used for the homogenization.
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Phase separation rinse—monolayer was cold with ice PBS for 5min. Lyse cells
was directly put into a clean experiment plate, then 1 ml of TRIZOL Reagent was added
to per 3.5 cm diameter dish and mixed with cell scraper.
Sample was past to lysate several time through a micro pipette. Then the cell
was homogenized through a vortex. Based on the area size of the dish used (96 holes),
TRIZOL 10µL reagent was put into plate then completely mixed by the micro pipette.
Otherwise, not enough amount of trizol reagent will lead to a contamination of DNA.
RNA precipitation—the RNA was precipitated from liquid phase through the
mixture of cell and isopropyl ethanol. In addition, 0.45ml of isopropyl ethanol is added
into per ml of TRIZOL reagent, mix well. Then used as initial homogenization.
Samples was incubated in the incubator 25°C for 10 to 15 min (depend on the
sample amount), then centrifuge at 11000 x g for 10 min at 4°C for pellet RNA.
RNA wash—after the centrifuge, supernatant was discarded completely,
precipitate was collected, washed with gradient alcohol. Every ml of TRIZOL reagent
was added more than 1ml of 75% alcohol. Vortex was used to mix these RNA
precipitate and TRIZOL together. Then centrifuge again at 7000 x g for at least 5min,
4°C. Above washing steps might have to be repeat according to the purity of the RNA
precipitate.
Spectrophotometric analysis—the RNA was diluted with DEPC-treated water at
1:40 ratio. 260nm and 280nm is used to detect sample concentration and purity. Once
the result of A260/A280 is larger than 1.6, then the convention that 1 OD at 260nm
equals 40µg /ml RNA.

17

2.2.3 mRNA purification.
Due to a strong inhibition effect of polysaccharide sulfate to both polymerase and
reverse transcriptase, the mRNA cannot be used to make standard cDNA. So mRNA
purification is necessary. According to the method published in 2013 by Dr. Viennois
(33), LiCl can be used to precipitate polysaccharide sulfate molecular. the RNA were
precipitated twice by 0.1 volume of 8 M LiCl, followed by a precipitation step in 0.1
volume of 3 M sodium acetate (pH 5.2) and 2 volumes of 100% ethanol. The RNA were
then centrifuged, pellets were washed with 100 µL of 70% ethanol and RNAs were
finally dissolved in 20-50 µl of RNase-free water.
2.2.3.1

Standard cDNA synthesis

Maxima First Strand cDNA Synthesis Kit for RT-qPCR from thermo scientific is
used to make standard cDNA. In the beginning, an ice box is prepared. Then a sterile
and RNAse-free tube is put on the ice. The reaction reagents were added into this order:
5x reaction mixture 4µL, maxima enzyme 2µL, template RNA 3µg, and nuclease-free
water 20 µL. the tube was mixed on vortex for 10 min. then centrifuged at 5000 rpm
4degree 10min. Precipitate was disgarded. And the supernate was incubated for 10min
at 25 ℃. And then incubated at 50 ℃ for 15min.
Due to the primer sequence is GC rich sequence, which is with a large amount of
secondary structure RNA template. The reaction temperature is increased to 65 ℃. The
terminate reaction temperature is set as 85 ℃ for 5min. The product is stored in -20
freezer.
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2.2.4 Cell biology and histology
Paraffin

embedding,

OCT

embedding,

sectioning,

H&E

staining,

immunofluorescence, immunohistochemistry were finished.
2.2.4.1

Paraffin embedding and sectioning.

Paraffin embedding—organs were dehydrated by being immersed into 50%
ethanol alcohol for 90 min, 70% ethanol alcohol for 90 min, 85% ethanol alcohol for 90
min, 95% ethanol alcohol for 90 min, 100% ethanol alcohol for 60 min twice.
Embedding—Organs were washed with xylene ethanol alcohol 1:1 mixture for 60
min, then washed with xylene for 60 min twice. After that, they were permeated by
xylene and paraffin 1:1 mixture for 90 min at 62 ℃, paraffin alone for 90 min at 62 ℃.
Histology Cassettes was used to form organs with hot flowing paraffin. Then the organs
included in paraffin solidified on the cold station for 5 h, then cassettes were put into 20 ℃ for 2 days.
Sectioning—Shandon™ Finesse™ 325 Manual Microtome (from thermo
scientific) is used to section paraffin embedding organs. The organs buried in the
paraffin were cut to 5 micrometer thick slices, then they were collected by ultraclear
microscope slides (from denville) 5 pieces of organs in a row. Then the slides were soak
in 42 ℃ water bath for 5 min to extend folded tissue. The slides were dried by a hotplate
at 35 ℃ for 20 min.
2.2.4.2

Hematoxylin and eosin (H&E) staining.

Slides were washed with xylene for 5 min 3 times to remove paraffin. Then they
were soaked into 100% ethanol alcohol for 10 min, 95% ethanol alcohol for 10 min, 70%
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ethanol alcohol for 5 min. After that, slides were rinsed in distilled water for 10 min.
Slides were stained in hematoxylin for 6min with holder. Then they were washed with
flowing tap water to wipe off attached hematoxylin then immersed in distilled water for 3
min. After washing, they were Decolorize in acidic alcohol just 1 tap or 1 second and
rinsed in distilled water 3 min again. Then slides were immersed into Eosin for 10
seconds. After that, slides were dehydrated by 70% ethanol alcohol washing for 10 min,
95% ethanol alcohol washing for 10 min, 100% ethanol alcohol washing for 5 min twice.
Sides were soaked into xylene 70% ethanol alcohol 1:1 solution for 1 min, and washed
by xylene for 1min as following. Cytoseal was used as mounting media to protect
covered tissues. Finally, stained slides were observed under a microscope (M130 from
denville).
2.2.4.3

Immunofluorescence

OCT slides were pre-observed and rinsed with ultrapure water for 10 min to
eliminate OCT. Then the tissues were completely oxidized by hydrogen peroxide for 30
min and washed with 1x PBS with calcium and magnesium for 10 min again. Then
slides were incubated with citrate buffer A (45 ml 0.1 M citrate buffer mixture with 205
ml 0.1 M sodium citrate buffer) for 10 min and cooled down. Washed again with 1x PBS
with calcium and magnesium for 10 min. Then the slides were blocked with blocking
buffer for 45 min at room temperature. After that, diluted primary antibody buffer was
incubated with slides for an hour at room temperature. Next, the slides were washed
again with 1x PBS for 3 min 3 times. Incubated with proper secondary antibody for 1
hour at room temperature as follows. Slides were covered with DAPI solution then
protected by microscope cover slides.
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Table 3: buffers used for IF

buffer

recipe

1x PBS

mix the following reagents into 500mL ultrapure water
80.00g of NaCl
2.00g of KCl
14.40g of Na2HPO4
2.40g of KH2PO4
Adjust pH to 7.40
Adjust volume to 1L with additional distilled H2O.
Then sterilize by autoclaving.

blocking buffer

To prepare 10 ml, add 0.5 ml BSA from the same species as the
secondary antibody to 9 ml 1X PBS) and vortex for 5 min. add 30 µl
Triton™ X-100 while stirring.

1° Ab

IL6, TNF alpha, P53 antibodies were used.
IL6 1µL to 1mL
TNF alpha 5µL to 1 mL
P53 2µL to 1 mL
Dilute antibody with blocking buffer at proper dilution ratio

2°Ab
citrate buffer A
DAPI

2.2.4.4

Goat anti-rabbit IgG (H+L) Secondary Antibody, Alexa Fluor® 488
conjugate. Dilution ration: 1:500 in
45 mL 0.1M citrate acid buffer mix with 205 mL 0.1M sodium citrate acid
buffer.
DAPI
concentration
was
0.5µg/mL
1xPBS.
Stored in 4 degree.

Immunohistochemistry

Slides were firstly washed by xylene for 10 min, then washed by 100% ethanol
alcohol washing for 5 min, 95% ethanol alcohol washing for 5 min, 70% ethanol alcohol
washing for 5 min twice. Then the tissues on the slides were fixed by formalin for 10 min,
then hydrogen peroxide was used to block the peroxidase. After washing with 1x PBS,
the slides were incubated with citrate buffer B for antigen retrieval. Pressure cooker
bottom was filled with distilled water, slides with citrate buffer was set in the container,
then cooked in high pressure for 10 min cooled for 1 hour on bench. The slides were
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completely cooled down, then washed with 1x TBS for 3 min 3 times. Then an immedge
pen was used to circle the tissue on the slides.
Blocked with blocking buffer at room temperature for 45 min as follows. After
blocking, those slides were incubated with primary antibody for 1 hour at room
temperature. Then the rest primary antibody buffer was washed with 1x TBS for 3 min 3
times. Slides was incubated with secondary antibody for 1 hour at room temperature.
Diluted DAB reaction buffer was dropped on the tissue circled for 5 min. Then DAB
buffer was washed by 1x PBS with calcium and magnesium. Slides were stained with
hematoxylin for 6 min and washed with 1x PBS. Finally, the tissues were protected with
cytoseal and covered.
Table 4: buffers used in IHC

buffer

1x PBS

1x TBS

blocking buffer

1° Ab
2°Ab
citrate buffer B

recipe
mix the following reagents into 500mL ultrapure water
80.00g of NaCl
2.00g of KCl
14.40g of Na2HPO4
2.40g of KH2PO4
Adjust pH to 7.40
Adjust volume to 1L with additional distilled H2O.
Then sterilize by autoclaving.
Dissolve the following reagents into 500mL tap water
6.05 g Tris
8.76 g NaCl
Adjust pH to 7.5 with 1 M HCl
make volume up to 1 L with H2O. TBS is stable at 4°C for 3 mo.
To prepare 10 ml, add 0.5 ml BSA from the same species as the
secondary antibody to 9 ml 1X PBS) and vortex for 5 min. add 30 µl
Triton™ X-100 while stirring.
IL6, TNF alpha, P53 antibodies were used.
IL6 1µL to 1mL
TNF alpha 5µL to 1 mL
P53 2µL to 1 mL
Dilute antibody with blocking buffer at proper dilution ratio
ABC kit from VECTOR LAB.
2.94g sodium citrate in 950mL dH2O
Adjusted pH to 6.0, add 0.5mL Tween-20, add dH20 up to 1L.
Mixed well
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DAPI concentration was 0.5µg/mL 1xPBS.
Stored in 4 degree.

DAPI

3
3.1

RESULTS

Synthesis analysis
3.1.1

13

C NMR

Fig.9 show the 13C NMR spectra of P and PS. Since PS is obtained from P and
pyridine –SO3 complex, there was not influence of the molar mass on the position of the
peaks. In other words, sulfonation was the only factor that is able to differ 13C NMRs
between P and PS. Due to a good solubility of P into water, D2O was chosen as the
solution of 13C NMR spectra.
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Figure 9: Pullulan (P) and pullulan sulfate (PS) C NMR spectrum confirmed sulfate group location.
Concentration:0.030g/0.5ml D2O. Range from 55ppm to 105ppm. Green line—PS, Red line—P

As a classic linear alpha glucan, pullulan has the representative feature of ring

carbohydrate. Thus the glucose ring is shown on the spectra. It could be seen that the
C-1 glucose ring carbon absorbed at 97.93, C-2 at 71.71, C-3 at 73.43, C-4 at 69.47, C-

23

5 at 70.33 and C-6 at 66.45 ppm (22-25). It has a high possibility that by branching at C4, down field shifted resonances was not detected. Thus introduction of sulfate groups
on pullulan might have a preference on taking place at the C-3. The ring carbons
reactivity was in the order C-3>C-2>C-4. The substitution of a hydrogen atom by a
sulfate group led to a down field shift of roughly 5 ppm of the appropriate C resonance
and to a high field shift at the neighbouring C atoms, (26, 27) caused by magnetic
anisotropy of the sulfate neighbouring groups. Since the local magnetic field was
averaged over all segment movements and since these movements were slow, the line
width was approximately 10 times larger than those of low-molecular materials. Due to
the installation of the heavy sulfate group this effect was stronger for the sulfates than
for the pure saccharides.
For the pulluan, no visible high field effect was observed at the C-6 and C-5
positions. The C-3 signal appeared at 77.58 ppm. Two additional smaller C-3 signals
appeared at 82.88 and 79.57 ppm, describing the sulfates at C-2 and C-4. Besides the
high field C-2 resonance at 71.87 ppm there was also a down field shifted signal of the
sulfated C-2 at 75.51 ppm. The signals at 70.85 and 70.27 ppm arose from the C-5.
This double split could be the result from a high field shift due to the sulfonation at the
C-4. The down field shifted C-4 signal was negligible with respect to the resonance of
the other signals. The 69.25 ppm peak was probably a high-field shifted resonance of
the sulfated C-4 which occurred when a sulfate group was attached at the C-3.
3.1.2 FTIR spectrum
There were two obviously characteristic absorption bands showed on TFIR
spectroscopy. On one hand, the peak at 1250 cm-1 indicated a sulfur atom and oxygen
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atom double band asymmetrical vibration. On the other hand, the one at 850 cm-1
referred to a symmetrical C-O-S vibration associated to a C-O-SO3 group. As for
pullulan spectrum, the 920

-1

band described alpha-(1.6) linkages. While alpha-(1. 4)

linkages were observed at 970 cm-1. Ring deformations and scaffold vibrations were
showed at 710, 650 cm-1. The absorptions at 850 and 765 cm_1 showed that pullulan
sulfate

had

a

4

C1

chair

conformation.

Figure 10: Sulfate group identification by IR spectrum of Pulluan and PS.Orange line—PS, pink line—
Pullulan

As for pullulan sulfate, the 815 cm-1 absorption band discribed a symmetrical C-O-S
vibration, with C-O-C bending vibration at 755 cm-1. Just like it is showed in Pullulan
spectrum, the ring deformation and scaffold vibrations were observed at 700 cm-1.
There was no influence of the polymer molar mass and only a marginal influence on the
degree of substitution. With increasing DS the intensity of the OH absorption band
decreased slightly. A similar result was found by Miyaji (34).
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3.2

Degree of substitution
Degree of substitution (DS) is detected gravimetrically. Accurate 1.0000g sample

was weight, and dissolved with 10mL HCl (10%). Then the solution was precipitated
with BaCl2 (25%). The precipitate was obtained by filtration, then washed with DI water
for an hour to make the solid ions free. Muffle oven was used to heat the solid to ash
(800℃ for 3h). The degree of substitution was calculated with following formula:



163.1559
4
233.4300  80.0660
4

Table 5: Measurement of the degree of substitution is detected gravimetrically.

temperature/℃

65

80

85

85

90

degree of
substitution

1.31

2.02

0.71

2.09

Carbonization

acid used per gram
polysaccharide/mL

8

8

4

8

8

ash weight/g

1.1419

1.4526

0.754

1.4775

NA

color

white
powder

yellow solid

white powder

yellow solid

dark solid

3.3

Anatomy
Mice were treated with regular food and 3 percent PS II in drinking water for a

span over 7 days, during the week, daily bodyweight change is recorded. Then those
mice were sacrificed. Shorter colon and bloody stools were found.
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Figure 11: PS II, CS and DSS induced colitis, confirmed by bodyweight change measurement. DSS—dextran
sulfate sodium; PS II—pullulan sulfate II (DS=2.1); PS I—pullulan sulfate I (DS=0.7); P—pullulan; C—cyclodextrin; CS—
cyclodextrin sulfate.

As shown in Fig. 11. PS II and DSS treated mice is keep losing weight over a
week. On the other hand, PS I and Pullulan group mice body weight are not changing,
even gain weight. Consider of those mice were 8 weeks old, and pullulan is a diet food,
the body weight change is normal compared to the PS II and DSS group. This is a solid
evidence that PS II induced IBD on those mice just ass DSS performed.

Figure 12: PS II induced colitis is confirmed by blood stools and diarrhea.
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5 mice were put in this box for 20 min. It is white background. And bloody stools
is everywhere.
Bloody stools is the classic feature of ulcerative colitis. Mice which is treated with
dextran sulfate sodium will have bloody stools on day 5. In this pullulan sulfate II group,
bloody stools was found on day 4. This support our hypothesis that pullulan sulfate has
a similar effect on inducing IBD on mice model, which is ulcerative colitis not Crohn’s
disease.

Figure 13: Colon length as colitis indicator compared to healthy colon.

7 centimeter long. No bleeding, no swelling is found. No erosion is found either.
Compare to normal colon from a healthy mouse. Inflammation colon is shorter.
Because mice body immune system is keeping killing inflammation cells. The
inflammation part is swelling and bleeding obviously. All this also supported our
ulcerative colitis model assumption. PS II just have same effect on inducing IBD
compared to DSS.
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Figure 14: Pullulan sulfate II (PS II) induced colitis.

Its 4 centimeter long. Bleeding, swelling, and shorter. The whole colon is with
erosion.

Figure 15: the specificity for colon is confirmed by the small intestine length.

Its 30 centimeter long. No bleeding, no swelling is found. No erosion is found
either. The whole small intestine is healthy, not inflammation feature is found.
On the other hand, unlike the colon, small intestine is free of the PS II affection. It
keeps just as seem as the healthy small intestine. In this case, it is 30 centimeter long.
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No bleeding, swelling and erosion is found.

Figure 16: Normal length of small intestine of pullulan sulfate II group confirming the specificity of
PSII for colon.

Its 30 centimeter long. No bleeding, no swelling is found. No erosion is found

either. The whole small intestine is healthy, not inflammation feature is found.

Figure 17: PS II, CS and DSS show shorter colon, which is a solid evidence of colitis. DSS—dextran
sulfate sodium; PS II—pullulan sulfate II (DS=2.1); PS I—pullulan sulfate I (DS=0.7); P—pullulan; C—cyclodextrin;
CS—cyclodextrin sulfate.
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Another typical feature of inflammation bowel disease is shorter colon. Due to the
inflammation, mice immune system is clearing those sick cells, mice have a shorter
colon.

Figure 18: Length of small intestine for polysaccharides tested. Inflammation is not
no present in the
small intestine. DSS—dextran
dextran sulfate sodium; PS II
II—pullulan sulfate II (DS=2.1); PS I—pullulan
pullulan sulfate I (DS=0.7);
P—pullulan; C—cyclodextrin; CS—cyclodextrin
cyclodextrin sulfate.

3.4

Histology
A

B

C

D

Figure 19: colitis is confirmed by histology (H&E staining.). DSS PSI and pullulan is used as control.

DSS—dextran sulfate sodium, PS II—low sulfate rate pullulan sulfate. P—
—pullulan.
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DSS, PS II, PS I and Pullulan were dissvoled with water at 3 percent
concentration.. And then feed to mice over a span of 7days. Then mice was sacrificed,
the colon was buried with paraffin and H&E staining. A: DSS colon, the base of crypt is
totally destroyed by the inflammation.

B: PS II colon, the base of crypt is totally

destroyed byy the inflammation
inflammation.. C: Pullulan colon, tissue remain integrated. No
inflammation was found. D: PS I colon, tissue remain integra
integrated.
ted. No inflammation was
found.
Histological appearance of the mice colonic mucosa after DSS administration.
Mucosal injury was produced and characterized by necrosis of epithelium, focal
ulcerative of the mucosa and diffused infiltration of n
neutrophil
eutrophil and lymphocyte (20x).
A

B

C

D

Figure 20: the specificity for colon is confirmed by histology (H&E staining). DSS PSI and pullulan is
used as control. DSS—dextran sulfate sodium, PS II—low sulfate rate pullulan sulfate. P—pullulan.

DSS, PS II, PS I and Pullulan were dissvoled with water at 3 percent
concentration. And then feed to mice over a span of 7days. Then mice was sacrificed,
the small intestine was buried with paraffin and H&E staining. A: DSS colon, the base of
crypt remains integrated, villus structure is clear and no inflammation was found. B: PS
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II small intestine, the base of crypt remains integrated, villus structure is clear and no
inflammation was found. C: Pullulan small intestine, tissue remain integrated. No
inflammation was found. D: PS I small intestine, tissue remain integrated. No
inflammation was found.
3.5

PCR

P
Figure 21: Colonic cytokine measurement (TNF alpha) using PS II induced colitis (fold expression
change of mRNA). P—pullulan, PS 1—low sulfate rate pullulan.PS II—high sulfate rate pullulan. DSS—dextran
sulfate sodium

TNF a is chosen as primer. PS II and DSS have an incredible increment compare
to Pullulan and PS I. thus inflammation is detected in PS II and DSS treated tissue.
Tumor necrosis factor (TNF alpha) is a well-known adipokine, which is used as
cell signaling protein. It is related to systemic inflammation and is able to make up an
acute reaction. TNF alpha can be generated by activated macrophages, CD4+
lymphoctyes, NK cells and eosinophils.
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The basic role of TNF alpha is to regulate body immune system. It can induce
fever, cachexia, inflammation even has potential to inhibit tumorigenesis. It also respond
to sepsis via IL 1 and IL 6 producing cells.
It is made use of a variety of human diseases, especially inflammatory bowel
disease (29). Fig 5 shows different expression of TNF alpha in colon and small intestine
tissue. In colon tissue, it has a significant expression on PS group and DSS group. And
no expression on P and PSI group. On the other hand, it has no obvious distinction
between PS, PS I, DSS and P groups.
In this case, In this case, PS II and DSS colon shows an absolutely higher TNF
alpha level compare to healthy tissue, thus pullulan and PS I group, which indicates the
inflammation.

P
Figure 22: Colonic cytokine measurement (IL-10) using PS II induced colitis (fold expression change
of mRNA). P—pullulan, PS 1—low sulfate rate pullulan .PS II—high sulfate rate pullulan. DSS—dextran sulfate
sodium.
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Interleukin-10, in short, IL-10 is a well-known anti-inflammation cytokine. It is
encoded IL-10 gene.
IL-10 protein is a homodimer, which is consisted with 178 amino acid.
In normal cells, IL-10 protein is inhibited, only very few amount IL-10 protein can
be detected. While in inflammation cells, as an anti-inflammation cytokine, it is highly
expressed to fix body inflammation. In other words, it will be obviously increased in
inflammation cells (31).
In this case, PS II is just as effective as DSS inducing IBD. Even stronger—PS II
has a 41 relatively fold change compare to DSS 22 fold change.
In this case, PS II and DSS colon shows an absolutely higher IL-10 level
compare to healthy tissue, thus pullulan and PS I group, which indicates the late severe
inflammation.

P
Figure 23: PS II induced colitis is confirmed by the fold change of cox 2 of colon. P—pullulan,
PS 1—low sulfate rate pullulan sulfate.PS II—high sulfate rate pullulan sulfate. DSS—dextran sulfate sodium
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Cyclooxygenase-2, in short Cox-2, is a primarily responsible for inflammation. In
1991, it is discovered that COX exists in 2 form, Cox-1 and Cox-2. Cox-2 is relative to
inflammation, but on the other hand, it is not for gastrointestinal integrity or platelet
aggregation, which means Cox-2 inhibiter will work as an anti-inflammation, but
minimize the risk of bleeding and gastrointestinal toxicity. Now it is developed and
people are already make benefits from it.
In our research, Cox-2 is chosen as another inflammation bio marker. In PS II
and DSS group, it shows a dramatic increment compare to P and PS I group, which
also proved our hypothesis that PS II works just same as DSS. PS II is able to induce
severe inflammation on colon tissue.
3.6

IHC
Immunohistochemistry is a very important and useful method to detect

inflammation on the digestive track.
IL-6 and TNF alpha are chosen as the detection bio- maker protein.
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Figure 24: PS II induced colitis is confirmed by IHC, IL-6 is used as primary antibody. A: pullulan
sulfate I (PS II) I colon. B: dextran sulfate sodium (DSS) colon. C: pullulan sulfate I (PS I) colon. D: pullulan (P) colon.

As shown in Fig 25, A and B is PS II and DSS tissue. The whole tissue is
anabrotic, base and base crypt is totally melt, cells is everywhere, and not organized.
Especially PS II, brown is DAB color of IL-6, while purple is hematoxylin counterstain.
The expression of the IL6 protein is significantly increasing in the colonic tissue attesting
of severe colitis. On the other hand. Hematoxylin is used as counterstain, there is no IL6 expression on C and D, but the purple color of hematoxylin. Which is a clear evidence
that PS II is able to induce severe inflammation on colon. And cooperation A and B. we
can tell that the whole tissue is broken in A, on picture B, there is some part is still
remain organized.
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Figure 25: IHC picture of IL-6 on small intestine tissue. A: pullulan sulfate II (PS I) I small intestine, B:
dextran sulfate sodium (DSS) small intestine, C: Pulluan (P) small intestine, D: pullulan sulfate I (PS I) small intestine.

As shown in Fig 26.there is no broken tissue is found. All the cells are
organized by its tissue, and no IL-6 expression is found on this picture. Only the
healthy tissue is shown by hematoxylin.
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Figure 26: IHC picture of TNF alpha on colon tissue. A: pullulan sulfate II (PS II) colon, B: dextran sulfate
sodium (DSS) colon, C: Pulluan (P) colon, D: pullulan (PS I) colon.

Figure 27: IHC picture of TNF alpha on small intestine tissue. A: pullulan sulfate II (PS II) small intestine,
B: dextran sulfate sodium (DSS) small intestine, C: Pulluan (P) small intestine, D: pullulan sulfate I (PS I) small
intestine.

As they are shown in Fig 27 and 28, there is a huge increment of TNF alpha
expression on PS II and DSS colon tissue, while the expression is lower on Pullulan and
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PS I group. Which means that healthy tissue does not have a large TNF alpha
expression, while the inflammation tissue has a lot.
The A and B of Fig 28 are less organized, which means the tissue is
histologically inflammation.

Figure 28: CS induced colitis is confirmed by IHC. CS colon (left) and normal colon (right).

In Fig. 28, IL-6 was used as 1° Ab to detect the inflammation on CS colon. There
is obviously IL-6 expression (brown color) on CS colon tissue, which indicates a strong
inflammation on the CS treated mice colon.
3.7

Histologic score
Histological scoring was decided by three factors.
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Figure 29: polysaccharide sulfates induced colitis is confirmed by histology scores.

Table 6 inflammation scoring is based on severity of inflammation, crypt damage and ulceration.

scores
0
1

2

severity of inflammation

crypt damage

ulceration

no inflammation was found

intact crypt

no ulcer

1/3 base lost

small spot of ulcer

2/3 base lost

3 or 4 foci of ulcer

whole base lost

extensive ulcer

granulocyte numbers was increasing
in lamina
inflammatory cells were found in the
submucosa

3

none

4

none

erosion on
epithelial surface

none

As it is shown above, Pullulan and Cyclodextrin do not induce inflammation. Low
degree of substitution pullulan barely induce colitis. PS II induced a stronger
inflammation on mice compare to DSS and CS.
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3.8

Immunofluorescence
Base on the paraffin sections, immunofluorescence is finished with IL-6, TNF

alpha and P53 used as primary antibody.
Recently, a high relative link between chronic inflammatory and cancer is found.
Which is supported by the negative regulation of NF-κB, a major inflammation regulator.
And P 53 is what it is relative to. P 53 is a major tumor suppressor.
However, for reasons, once the P53 is active, NF-κB activity, inflammation and
immune responses will be decreased. Therefore, P53 has anti-cancer function.

Figure 30 : PS II induced colits is cinfirmed by IF colon data, P53 is used as 1° Ab. P 53 is used as 1°
Ab. A: P 53 on PS II colon. B: DAPI on same tissue of A. C: P53 on DSS colon. D: DAPI on same tissue of C. E: P53
on PS I colon. F: DAPI on same tissue of E. G: P53 on Pullulan colon. H: DAPI on same tissue of G.
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Figure 31: the specificity for colon is confirmed by IF small intestine data, P53 is used as 1° Ab. A: P53 on
PS II small intestine. B: DAPI on same tissue of A. C: P53 on DSS small intestine. D: DAPI on same tissue of C. E:
P53 on PS I small intestine. F: DAPI on same tissue of E. G: P53 on Pullulan small intestine. H: DAPI on same
tissue of G.
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As shown in Fig 33, P 53 is used as primary antibody. To observe the P 53
(green) of Pullulan and PS I group, a longer exposure time is used compare DAPI. On
the other hand, DSS and PS II group even take a shorter exposure time to observe the
P 53 (green). Which means that DSS and PS II have a strong fluorescence signal
compare to PS I and Pullulan group. Thus DSS and PS II have a high P53 level. Which
indicates that there is strong inflammation in PS II and DSS treated mice colon, while no
inflammation is found in Pullulan and PS I treated mice.
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Figure 32: PS II induced colitis is confirmed by IF, IL-6 is used as 1° Ab. A: IL-6 on PS II colon. B: DAPI on
same tissue of A. C: IL-6 on DSS colon. D: DAPI on same tissue of C. E: IL-6 on PS I colon. F: DAPI on same tissue
of E. G: IL-6 on Pullulan colon. H: DAPI on same tissue of G.

As shown in Fig34, all P53 group (green) used 400ms to expose, while DAPI
(blue) just use 50µs. which still indicates that no difference of P53 expression of PS II,
DSS, PS I and Pullulan. This proved the inflammation selectivity on colon.
As shown in Fig34, Il-6 is used as primary antibody. To observe the IL-6 (green)
of Pullulan and PS I group, a longer exposure time is used compared to DAPI. On the
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other hand, DSS and PS II group even take a shorter exposure time to observe the IL-6
(green). But still, we didn’t observe any green (IL-6). This indicates that DSS and PS II
have a strong fluorescence signal compare to PS I and Pullulan group. Thus DSS and
PS II have a high IL-6 level.

Figure 33: IF small intestine data, IL-6 is used as 1° Ab. A: IL-6 on PS II small intestine. B: DAPI on
same section slide of A. C: IL-6 on DSS small intestine. D: DAPI on same section slide of C. E: IL-6 on PS I small
intestine. F: DAPI on same section slide of E. G: IL-6 on Pullulan small intestine. H: DAPI on same section slide of
G.

However, as shown in Fig 35. For all IL-6 group (green), a much longer exposure
time is used, 400ms. And all the DAPI group, which is blue, a shorter exposure time (50
µs) is applied. However, we are not able to confirm IL-6 in PS II small intestine. This
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Figure 34: the specificity of PS II induced colitis for colon is confirmed by IF liver picture.
IL-6 is used as 1° Ab. A: IL-6 on PS II liver. Exposure time 400ms. B: DAPI on same tissue of A.
exposure time 50µs. C: IL-6 on DSS liver. Exposure time 400ms. D: DAPI on same tissue of C. exposure
time 50µs. E: IL-6 on PS I liver. Exposure time 400ms. F: DAPI on same tissue of E. exposure time 50µs.
G: IL-6 on Pullulan liver. Exposure time 400ms. H: DAPI on same tissue of G. exposure time 50µs.

result means, in small intestine, IL-6 is not expressed. Thus PS II has an inflammation
selectivity on colon.
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We also tried IL-6 on liver tissue. All IL-6 picture share a long exposure time of

Figure 35: CS induced colitis is confirmed by IF, IL-6 is used as 1° Ab.

400ms, while the DAPI picture share a short exposure time of 50µs. Thus the IL-6 stays
inhibited in liver, due to the positive relation between IL-6 and inflammation, no
inflammation is found in liver, which proved the specificity of PS II induced colitis for
colon.
To detect the inflammation on CS colon tissue, IL-6 is used as 1° Ab, which
shows IL-6 (green) (left). DAPI is used as counterstain, which shows DAPI (blue, on the
right). The IL-6 is obviously increasing.

Figure 36: the specificity of CS induced colitis for colon is confirmed by IF pictures of CS small
intestine, IL-6 is used as 1° Ab.
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However, no IL-6 signal (green) is found at same exposure time: 40µs. only DAPI
(blue) can be seen. Which indicates that no IL-6 expressed in small intestine after 7
days CS treatment on mice.

4

CONCLUSIONS

A series of experiments were finished including primary organic compound
synthesis, animal experiments and advanced biochemistry analysis methods. A
high degree of substitution Pullulan (PS II), a low degree of substitution Pullulan (PS
I) and cyclodextrin sulfate were successfully synthesized with pyridine sulfate
complex, then preliminarily purified. The sulfate group was verified and the sulfate
rate of substitution was detected by gravimetric system.
Polysaccharide sulfates were fed to mice in 3% drinking water over a period of 7
days, the body weight change is recorded every day. PS II and CS showed a better
time effect on inducing IBD over a span of 6days compared to DSS model which
need a week. Furthermore, the anatomy also proved the inflammation by the
appearance of shorter colon, bleeding in colon, swelling colon and bloody stool. CS
and PS II kept mice losing weight just as DSS performed.
H&E staining showed relatively similar level of inflammation to the DSS for the colon
cross section. On the other hand, no inflammation was found in small intestine and
liver cross section.
Pullulan sulfate successfully induced inflammatory markers as shown by the qPCR
data: IL10, Cox-2, TNF alpha.
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Immunofluorescence indicated that PS II and CS both were able to increase the P
53 and IL-6 in mice colon. The specificity on colon other than small intestine also
proved the inflammation is UC not CD.
The selective location—colon, also indicated that the inflammation is UC not CD.
On the other hand, no inflammation occurred in small intestine and liver, which is
also proved by histology, immunofluorescence and immunohistochemistry. The
hypothesis that pullulan sulfate and cyclodextrin sulfate show at least same ability
on inducing inflammation on colon was supported by all these evidence.
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APPENDICES
(A) 1H NMR

1

Figure 37: H NMR spectrum of pullulan

1

Figure 38: H NMR spectrum of pullulan sulfate
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(B)
Table 6, qPCR primer sequence

Primer

Sequence (Sense, Antisense)

Mouse

5’- CCGGAGAGGAGACTTCACAG -3’

IL-6

Product
Size, bp

Cycle
Number

Annealing
T°C

421

30

62

290

24

65

450

15

65

554

32

5’- GGAAATTGGGGTAGGAAGGA -3’

5’TACTGAACTTCGGGGTGATTGGTCC
-3’
Mouse
TNF-a

5’CAGCCTTGTCCCTTGAAGAGAACC 3’

Mouse
GAPDH

5’- ACCACAGTCCATGCCATCAC -3’
5’- CACCACCCTGTTGCTGTAGCC -3’

Mouse

5’- TTCAACTCTGTCTCCTTCCT-3’

P53

5’- CAGCCCTGTCGTCTCTCCAG-3’
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